<DOC>
	<DOCNO>NCT00875849</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , cisplatin , work different way stop growth tumor cell , either kill cell stop divide . Radiation therapy use high-energy x-ray kill tumor cell . Monoclonal antibody , cetuximab , block tumor growth different way . Some block ability tumor cell grow spread . Others find tumor cell help kill carry tumor-killing substance . Giving chemotherapy together radiation therapy cetuximab may kill tumor cell . PURPOSE : This phase II trial study well chemotherapy give together radiation therapy cetuximab work treat patient head neck cancer .</brief_summary>
	<brief_title>Chemotherapy , Radiation Therapy , Cetuximab Treating Patients With Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Evaluate disease-free survival 2 year patient poor prognosis squamous cell carcinoma head neck treat chemoradiotherapy cetuximab complete surgical resection . Secondary - Evaluate quality life . - Evaluate tolerability . - Evaluate overall survival . - Analyze germinal polymorphism . OUTLINE : This multicenter study . Patients receive cetuximab IV day 1 . Treatment cetuximab repeat every week 8 course . Patients also receive cisplatin IV day 8 . Treatment cisplatin repeat every 3 week 3 course . Patients undergo concurrent radiotherapy 5 time week 7 week begin day 8 . After completion study treatment , patient follow 1 month every 3 month 2 year .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma oral cavity , oropharynx , hypopharynx , larynx Must undergone complete macroscopic resection Presence â‰¥ 1 follow poor prognostic factor complete resection : Incomplete microscopic resection N+ Complete microscopic resection &gt; 2 N+ Vascular and/or lymphatic embolism At least 2 peripheral nerve invasion Positive surgical margin pT4 lesion No metastases PATIENT CHARACTERISTICS : WHO performance status 02 ANC &gt; 1,500/mm^3 Platelet count &gt; 100,000/mm^3 Hemoglobin &gt; 9 g/dL Bilirubin &lt; 1.5 time upper limit normal ( ULN ) Serum creatinine &lt; 1.25 time ULN and/or creatinine clearance &gt; 55 mL/min Not pregnant nursing Fertile patient must use effective contraception No serious disable cardiac , renal , hepatic , respiratory failure No coronary artery disease myocardial infarction within past year No uncontrolled cardiac arrhythmia Other active serious disease allow discretion investigator No known severe allergy cisplatin , cetuximab , excipients No malignant disease diagnose within past 5 year except basal cell carcinoma skin situ cervical cancer No psychological , familial , social , geographic situation preclude clinical follow PRIOR CONCURRENT THERAPY : No prior treatment ( except surgery ) cancer another head neck cancer At least 3 month since prior treatment investigational agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage I squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage II squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage I squamous cell carcinoma larynx</keyword>
	<keyword>stage II squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage I squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage II squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage I squamous cell carcinoma oropharynx</keyword>
	<keyword>stage II squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>tongue cancer</keyword>
</DOC>